Omada Health Expands GLP-1 Care Access via Lilly Employer Connect Partnership
Event summary
- Omada Health joins Lilly’s Employer Connect program as an independent program administrator, offering GLP-1 Care Track for employers.
- Omada’s GLP-1 Care Track includes clinical evaluation, prescribing, and ongoing medication management, integrated with Lilly’s Employer Connect.
- Survey of 3,000 non-Omada GLP-1 patients reveals gaps in primary care support, with 61% wanting more time to discuss weight loss and 44% feeling their PCP is too busy.
- Omada’s GLP-1 care track is now available through three leading pharmacy benefit manager solutions, direct-to-employer programs, and cash-pay options.
- Omada reports that members who persisted on GLP-1 medication for 12 months achieved 18.4% average weight loss, compared to 11.9% in real-world evidence.
The big picture
Omada Health’s partnership with Lilly Employer Connect underscores the growing demand for comprehensive obesity management solutions. As employers struggle with rising costs and limited coverage options for GLP-1 medications, Omada’s multi-channel approach aims to provide flexible, transparent solutions. The integration of lifestyle support with medication management highlights a broader industry shift towards holistic care models for chronic conditions.
What we're watching
- Market Penetration
- How Omada’s expanded access pathways will affect adoption rates among employers and patients.
- Cost Sustainability
- Whether Omada can maintain predictable cost structures for employers while managing rising out-of-pocket expenses for patients.
- Care Coordination
- The pace at which Omada can integrate lifestyle support with GLP-1 therapy to improve long-term patient outcomes.
Related topics